South Dakota · 52354

Biopsy And/or Destruction Of Growth Of Ureter Or Kidney Using An Endoscope in South Dakota

South Dakota Medicare Avg
$302.73
35% below national avg
National Medicare Avg
$468.02
All states combined
Billed Charge (SD)
$1,290.77
What providers submit
Est. Commercial (SD)
$791.52
National avg: $1,323.41
Est. Cash / Self-Pay (SD)
$644.54
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

49
Services in SD
16
Providers
N/A
Min Payment
N/A
Max Payment

South Dakota Pricing in Context

In South Dakota, CPT code 52354 (Biopsy And/or Destruction Of Growth Of Ureter Or Kidney Using An Endoscope) carries an average Medicare payment of $302.73 — 35% below the national benchmark of $468.02. 16 providers across the state submitted claims for this procedure in 2023, performing 49 total services. Individual payments in SD ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in South Dakota is $1,290.77, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because South Dakota sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Urinary Surgery procedures, the estimated commercial insurance price in South Dakota lands near $791.52, with self-pay cash prices typically around $644.54. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Biopsy And/or Destruction Of Growth Of Ureter Or Kidney Using An Endoscope cost in South Dakota?

The average Medicare payment for Biopsy And/or Destruction Of Growth Of Ureter Or Kidney Using An Endoscope in South Dakota is $302.73, which is 35% below the national average of $468.02. Providers in SD typically bill $1,290.77 for this procedure.

What does Biopsy And/or Destruction Of Growth Of Ureter Or Kidney Using An Endoscope cost with insurance in South Dakota?

With commercial insurance in South Dakota, Biopsy And/or Destruction Of Growth Of Ureter Or Kidney Using An Endoscope costs an estimated $791.52. Without insurance, the estimated cash price is $644.54. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Biopsy And/or Destruction Of Growth Of Ureter Or Kidney Using An Endoscope in South Dakota?

16 providers in South Dakota billed Medicare for Biopsy And/or Destruction Of Growth Of Ureter Or Kidney Using An Endoscope in 2023, performing 49 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Biopsy And/or Destruction Of Growth Of Ureter Or Kidney Using An Endoscope cheaper in South Dakota than the national average?

Yes — Biopsy And/or Destruction Of Growth Of Ureter Or Kidney Using An Endoscope costs 35% below the national average in South Dakota. The state average Medicare payment is $302.73 compared to $468.02 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial